 Papillomavirus Infections
"Papillomavirus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
| Descriptor ID |
D030361
|
| MeSH Number(s) |
C02.256.650 C02.928.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Infections".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Infections".
- Papillomavirus Infections
- Warts
This graph shows the total number of publications written about "Papillomavirus Infections" by people in UAMS Profiles by year, and whether "Papillomavirus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2019 | 1 | 1 | 2 | | 2018 | 1 | 1 | 2 | | 2017 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 | | 2015 | 3 | 0 | 3 | | 2013 | 2 | 0 | 2 | | 2011 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Papillomavirus Infections" by people in Profiles over the past ten years.
-
Bumatay S, Dickinson C, Larsen R, Stock I, Day MR, Hatch B, Robison S, Darden PM, Sullivan E, Carney PA. A comparison of electronic health records and the Oregon state immunization registry for human papilloma virus vaccine delivery (2005-2022). Vaccine. 2023 09 07; 41(39):5758-5762.
-
Hatch BA, Valenzuela S, Darden PM, Fagnan LJ, Dickinson C, Marino M, Robison SG, Larsen R, Carney PA. Clinic-level differences in human papillomavirus vaccination rates among rural and urban Oregon primary care clinics. J Rural Health. 2023 03; 39(2):499-507.
-
Aydin AM, Hall M, Bunch BL, Branthoover H, Sannasardo Z, Mackay A, Beatty M, Sarnaik AA, Mullinax JE, Spiess PE, Pilon-Thomas S. Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients. Int Immunopharmacol. 2021 May; 94:107481.
-
Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Lobaugh SM, Grecula JC, Mitchell DL, Wobb JL, Miller ED, Blakaj DM, Diavolitsis VM, Lee N, Bhatt AD. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer. Int J Cancer. 2020 07 01; 147(1):107-115.
-
Carney PA, Hatch B, Stock I, Dickinson C, Davis M, Larsen R, Valenzuela S, Marino M, Darden PM, Gunn R, Ferrara L, Fagnan LJ. A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices. Implement Sci. 2019 03 14; 14(1):30.
-
Rand CM, Schaffer SJ, Dhepyasuwan N, Blumkin A, Albertin C, Serwint JR, Darden PM, Humiston SG, Mann KJ, Stratbucker W, Szilagyi PG. Provider Communication, Prompts, and Feedback to Improve HPV Vaccination Rates in Resident Clinics. Pediatrics. 2018 04; 141(4).
-
Rand CM, Tyrrell H, Wallace-Brodeur R, Goldstein NPN, Darden PM, Humiston SG, Albertin CS, Stratbucker W, Schaffer SJ, Davis W, Szilagyi PG. A Learning Collaborative Model to Improve Human Papillomavirus Vaccination Rates in Primary Care. Acad Pediatr. 2018 03; 18(2S):S46-S52.
-
Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. JAMA Oncol. 2017 Jun 01; 3(6):833-837.
-
Hernandez AL, Karthik R, Sivasubramanian M, Raghavendran A, Gnanamony M, Lensing S, Lee JY, Kannangai R, Abraham P, Mathai D, Palefsky JM. Prevalence of Anal HPV Infection Among HIV-Positive Men Who Have Sex With Men in India. J Acquir Immune Defic Syndr. 2016 Apr 01; 71(4):437-43.
-
Coleman HN, Greenfield WW, Stratton SL, Vaughn R, Kieber A, Moerman-Herzog AM, Spencer HJ, Hitt WC, Quick CM, Hutchins LF, Mackintosh SG, Edmondson RD, Erickson SW, Nakagawa M. Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination. Cancer Immunol Immunother. 2016 May; 65(5):563-73.
-
Roberts JR, Naifeh M, Jacobson RM, Hinton E, O'Brien E, Rogacki B, Thompson D, Margolis B, Darden PM. Adolescent Vaccination Performance in South Carolina Compared to the United States. J S C Med Assoc. 2015 Dec-2016 Jan; 111(4):117-21.
-
Moerman-Herzog A, Nakagawa M. Early Defensive Mechanisms against Human Papillomavirus Infection. Clin Vaccine Immunol. 2015 Aug; 22(8):850-7.
-
Nakagawa M, Greenfield W, Moerman-Herzog A, Coleman HN. Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines. Clin Vaccine Immunol. 2015 Jul; 22(7):679-87.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|